Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $38.22B | $345.00 | $390.88 | 13.30% | Strong Buy | 8 | 128.29% | 1,035.81% | 3,703.46% | 2,003.62% | |||
| NVO | NOVO NORDISK A S | $261.86B | $58.93 | $57.40 | -2.60% | Buy | 5 | 96.31% | 96.77% | 501.77% | 166.41% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $44.80B | $339.11 | $494.90 | 45.94% | Strong Buy | 20 | 37.50% | 309.13% | 1,650.79% | 79.58% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.39B | $44.67 | $52.00 | 16.41% | Strong Buy | 5 | 25.67% | 80.32% | 42.45% | 31.91% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $526.94M | $9.36 | $22.00 | 135.04% | Strong Buy | 3 | 53.52% | 77.67% | 139.83% | 68.93% | |||
| CORT | CORCEPT THERAPEUTICS INC | $4.28B | $40.71 | $100.00 | 145.64% | Buy | 3 | 43.50% | 97.45% | 128.08% | 98.27% | |||
| VCEL | VERICEL CORP | $1.87B | $36.94 | $45.00 | 21.82% | Strong Buy | 1 | 21.67% | 84.43% | 29.97% | 21.28% | |||
| ARGX | ARGENX SE | $51.01B | $835.68 | $1.03k | 23.07% | Strong Buy | 16 | 1,549.26% | 24.66% | 54.36% | 46.18% | |||
| ABEO | ABEONA THERAPEUTICS INC | $280.17M | $5.17 | $20.00 | 286.85% | Buy | 2 | 817.16% | 17.10% | 81.99% | 60.75% | |||
| TECH | BIO-TECHNE CORP | $10.17B | $65.25 | $69.00 | 5.75% | Strong Buy | 7 | 6.20% | 72.83% | 22.68% | 17.65% | |||
| ADMA | ADMA BIOLOGICS INC | $4.16B | $17.50 | N/A | N/A | N/A | N/A | 27.01% | 23.80% | 114.85% | 87.08% | |||
| GMAB | GENMAB A | $21.36B | $33.27 | $43.25 | 30.00% | Strong Buy | 4 | 16.73% | 133.17% | 30.51% | 24.99% | |||
| KRYS | KRYSTAL BIOTECH INC | $8.19B | $282.27 | $302.83 | 7.28% | Strong Buy | 6 | 36.77% | 30.08% | 75.26% | 69.06% | |||
| MNKD | MANNKIND CORP | $1.85B | $6.01 | $10.08 | 67.77% | Strong Buy | 6 | 22.16% | 63.97% | -453.45% | 40.84% | |||
| VCYT | VERACYTE INC | $3.02B | $38.16 | $46.33 | 21.42% | Buy | 6 | 13.14% | 72.68% | 14.91% | 13.71% | |||
| RPRX | ROYALTY PHARMA PLC | $24.45B | $42.36 | $47.75 | 12.72% | Strong Buy | 4 | 18.78% | 57.52% | 40.57% | 20.18% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.01B | $15.22 | $17.33 | 13.88% | Buy | 3 | 20.04% | 30.63% | 46.23% | 32.06% | |||
| XOMA | XOMA ROYALTY CORP | $327.78M | $26.47 | $72.67 | 174.53% | Strong Buy | 3 | 41.73% | 37.69% | N/A | N/A | |||
| NAGE | NIAGEN BIOSCIENCE INC | $486.02M | $6.09 | $13.00 | 113.46% | Strong Buy | 2 | 23.38% | 31.11% | 72.56% | 52.26% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $3.90B | $197.93 | $243.50 | 23.02% | Strong Buy | 6 | 14.25% | 69.68% | 24.08% | 15.49% | |||
| APLS | APELLIS PHARMACEUTICALS INC | $2.89B | $22.83 | $34.54 | 51.28% | Buy | 13 | 7.61% | 34.96% | 57.08% | 21.63% | |||
| EXEL | EXELIXIS INC | $11.48B | $42.81 | $44.78 | 4.60% | Buy | 9 | 13.08% | 24.81% | 71.97% | 55.08% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.76B | $74.45 | $78.56 | 5.52% | Buy | 9 | 18.23% | 29.49% | 223.75% | 50.76% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $209.10M | $2.60 | $12.00 | 361.54% | Buy | 1 | 15.12% | 152.57% | 29.17% | 18.76% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.07B | $25.00 | $33.00 | 32.00% | Strong Buy | 1 | 9.07% | 20.02% | 57.36% | 50.19% | |||
| CRMD | CORMEDIX INC | $643.71M | $8.17 | $15.40 | 88.49% | Buy | 5 | 28.10% | 2.43% | 70.46% | 35.11% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $119.76B | $472.01 | $509.81 | 8.01% | Strong Buy | 21 | 10.81% | 20.59% | 41.92% | 29.20% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.13B | $57.95 | $87.83 | 51.57% | Strong Buy | 12 | 9.11% | 35.63% | 24.27% | 19.30% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.18B | $37.84 | $44.50 | 17.60% | Strong Buy | 6 | 16.91% | 36.05% | 77.91% | 53.85% | |||
| UTHR | UNITED THERAPEUTICS CORP | $20.45B | $475.00 | $514.18 | 8.25% | Buy | 11 | 11.37% | 8.75% | 27.79% | 24.91% | |||
| MDXG | MIMEDX GROUP INC | $753.84M | $5.09 | $10.00 | 96.46% | Strong Buy | 2 | 14.15% | 33.63% | N/A | N/A | |||
| INVA | INNOVIVA INC | $1.57B | $20.98 | $32.25 | 53.72% | Buy | 4 | 10.65% | 12.32% | 25.83% | 18.25% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $79.35B | $755.02 | $814.40 | 7.86% | Buy | 20 | 8.24% | 10.35% | 22.36% | 17.24% | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.42B | $26.13 | $31.42 | 20.23% | Buy | 12 | 12.20% | 5.65% | 46.60% | 32.12% | |||
| INCY | INCYTE CORP | $20.16B | $102.67 | $106.00 | 3.24% | Buy | 13 | 10.33% | 18.91% | 19.99% | 14.69% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.